INNOVATIONS IN THE TREATMENT OF INFLUENZA AND ARVI IN CHILDREN UNDER ONE YEAR OF AGE

Аннотация

Acute respiratory viral infections (ARVI), including influenza, are among the most common illnesses in early childhood, posing a significant risk for infants under one year of age. Children in this age group have an immature immune system and limited physiological reserves, making them more vulnerable to severe complications such as pneumonia, bronchiolitis, and in rare cases, respiratory failure. Traditional antiviral therapies and supportive measures are often constrained by age-related safety and efficacy issues. Therefore, exploring innovative treatment methods is crucial to improving clinical outcomes, reducing hospitalization rates, and preventing long-term sequelae in this high-risk population.